PharmiWeb.com - Global Pharma News & Resources

Articles

Do medical device manufacturers bring new advantages to labelling compliance thanks to their engineering-orientated approach? asks Kallik’s David Bennett
Do medical device manufacturers bring new advantages to labelling compliance thanks to their engineering-orientated approach? asks Kallik’s David Bennett In the pharmaceutical world, labelling change management is a complex enough affair already. But it’s made all the more challenging because the physical labelling side tends to be handled by regulatory and manufacturing teams, while the artwork by design teams is typically managed at third-party agencies. None of this is well coordinated and it can be difficult to see the current status of output, the likely impact of planned changes, and what will be involved to roll out these changes wh…
Challenging the problem of rising obesity levels, musculoskeletal injuries and liable in NHS mortuaries.
By Sharon Rindsland, Senior Manual Handling Co-ordinator, East Kent Hospitals Since 1975 worldwide obesity has nearly tripled. In 2016, more than 1.9 billion adults were classed as being overweight, of these 650 million were obese. However, this doesn’t just apply to adults, over 340 million children and adolescents aged 5-19 were overweight or obese in 2016 . Unfortunately, complications related to obesity continue post-mortem. Nursing staff and mortuary technicians often face these complications when processing and transferring overweight patients. Issues such as loss of dignity for the patient, difficulty transferring patients resulting in musculoskeletal injuries (MSI) for staff, inc…
Enzymes are a class of biological catalysts. They govern many catalytic processes such as metabolism, nutrition, and energy conversion of organisms. Most of the reactions closely related to life processes are enzyme-catalyzed reactions.
Catalysis Enzymes are a class of biological catalysts. They govern many catalytic processes such as metabolism, nutrition, and energy conversion of organisms. Most of the reactions closely related to life processes are enzyme-catalyzed reactions.   These properties of the enzyme enable the intricate process of material metabolism in the cell to proceed in an orderly manner, and to adapt material metabolism to normal physiological functions. If an enzyme is defective due to genetic defects, or the enzyme activity is weakened by other reasons, it can caus…
In order to carry out various life activities, the organism must obtain energy and produce new substances needed for its growth.
In order to carry out various life activities, the organism must obtain energy and produce new substances needed for its growth. By ingesting nutrients, organisms produce energy through decomposition; or produce new substances through synthesis. In organisms, nutrition molecules participate in various decomposition and synthesis reactions, collectively known as metabolism.   Any substance has more or less energy. When a substance changes through a chemical reaction, it will take a long time to complete under the condition of no external force. This long-term reaction is not enough to maintain life activity of the organism. Therefore, organisms have developed…
The pharmacovigilance industry is competitive in nature with key companies involved in continuous product development, collaborations, partnerships and alliances to augment market penetration.
According to the World Health Organization’s (WHO) report on pharmaceuticals consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital set ups. Owing to this, there has been a significant rise in the number of medicines made available to healthcare consumers. Rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities. The companies operating in the pharmacovigilance market are un…
Anti-aging is intensively discussed nowadays. This article talks about the factors and biomarkers that relates to aging.
Exercise and aging Although lots of money and efforts have been invested into drug development, no drug is found to be effective in combatting aging. It is important to note that exercise is a truly effective anti-aging measure. In the absence of suitable treatments for age-related dysfunction, exercise is currently the only intervention that shows significant efficacy, reducing the incidence of age-related diseases, improving quality of life, and even increasing the life expectancy of the human body. Even moderate exercise can bring seeable benefits. Although key molecular participants mediating the protective effects of exercise on age-related diseases are not yet known…
The convergence of information technology with medical devices is transforming the landscape of patient care. Medical devices integrated with mobile applications for monitoring and diagnosis of disease conditions reduces cost of diagnosis.
Smart medical devices refers to the electrical devices that have an autonomous processing system within them and are used to monitor a range of health and fitness parameters on an everyday basis. These devices provide a multitude of advantages to the patient and caregiver in monitoring and measuring various healthcare regimens such as sensing the lowered levels of insulin through artificial intelligence among type 1 diabetes patients and delivering insulin. Smart medical devices have radically changed the perspective of disease management by offering eas…
Patient Handling Equipment Market Share, Strategies, Emerging Technologies, Growth Rate Analysis, Trends and Forecast Report
A report by the United Nations Department of Economic and Social Affairs said that the global population of people in the 60 and above age group is rising rapidly. By the end of 2050, the global share of this age group is expected to grow to 21.1% from 11.7% in 2013. Additionally, the number of people in this age group is predicted to be around 324 million in India, 437 million in China, 58 million in Brazil, and 107 million in the U.S. by 2050. One of the major contributors of the growing elderly population is the increasing life expectancy rate. With the improvements in modern medicine and healthcare facilities, the average lifespan of elderly people has increased…
With the society becoming ever more egalitarian, there’s an increasing concern among dads at work regarding policies that support work-life balance.
But, when it comes to offering support to new parents, much focus is on relieving new mothers. We see companies all over the world boasting of their family-friendly policies. They’re going out of the way to provide young mothers with paid maternity leave, in-house day-care, nursing breaks, part-time and/or remote work options, and more. But, what about new dads? Are they getting the same level of support? Why does it even matter? In this article, we’ll take a look at the current situation of work-life balance among working dads, focussed particularly in the biotech and pharmaceutical industries. We’ll identify some of the key factors that dist…
. The first ever clinical study evaluating combined transcranial direct current stimulation (tDCS) and behaviour therapy could point to a new treatment for depression. The clinical pilot study is being undertaken by Flow Neuroscience, Europe’s first, and only...
London, UK. The first ever clinical study evaluating combined transcranial direct current stimulation (tDCS) and behaviour therapy could point to a new treatment for depression. The clinical pilot study is being undertaken by Flow Neuroscience, Europe’s first, and only, medically approved, at-home treatment for depression, which comprises a tDCS headset device and behaviour therapy app. The results will help the process of getting the Flow device reimbursed by healthcare providers, including the UK’s NHS. The independent study will…
As new device identification and traceability measures become compulsory in 2020 under MDR, Kallik’s Bob Tilling explores the outstanding labelling challenges for manufacturers.
As new device identification and traceability measures become compulsory in 2020 under MDR, Kallik’s Bob Tilling explores the outstanding labelling challenges for manufacturers. From May 2020, new medical devices sold in the EU must comply with new Medical Device Regulation (MDR) requirements. So how well prepared are manufacturers as the deadline approaches, and what challenges remain? 1.      Starting from scratch: the pain of playing catch-up Many medical device manufacturers have been caught off-guard by just how demanding this wholescale process change can be. Preparing for MDR has been…
In December 2016, a pharmacist in Northern Ireland made a tragic error when he fatally dispensed propranolol to a patient who was prescribed prednisolone. It was revealed that the two boxes were side-by-side on the pharmacy’s shelf, with similar branding and packaging. Such simple slip-ups can result in devastation and highlight packaging’s crucial role in keeping patients safe.
In December 2016, a pharmacist in Northern Ireland made a tragic error when he fatally dispensed propranolol to a patient who was prescribed prednisolone. It was revealed that the two boxes were side-by-side on the pharmacy’s shelf, with similar branding and packaging. Such simple slip-ups can result in devastation and highlight packaging’s crucial role in keeping patients safe. Here, Oliver Pittock managing direc…
Research Nester released a report titled “Prophylactic HIV Drugs Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global prophylactic HIV drugs market in terms of market segmentation by drug, by dosage form, by distribution channel and by region.
The market for prophylactic HIV drugs is anticipated to grow by a significant CAGR during the forecast period, i.e., 2019-2027. According to the World Health Organization, an estimated 3.5 million people were living with HIV in Americas in 2018 while around 2.5 were living with HIV in Europe. The highest occurrence of this disorder was in the Africa region, with an estimated 25.7 million people living with the disease in the same year. The market is segmented by drug, by dosage form, by distribution…
Research Nester released a report titled “Chronic Kidney Disease Drugs Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global chronic kidney disease drugs market in terms of market segmentation by drugs and by region.
The market for chronic kidney disease drugs is estimated to grow at a CAGR of about 4.5% during the forecast period, i.e., 2019-2027. The market is segmented by drug and by region, out of which, the drug segment is further segmented into antihypertensive agents, erythropoiesis-stimulating agents (EPAs), diuretics and others. Based on these, the antihypertensive agents segment is predicted to observe the highest growth over the forecast period on account of a greater demand for these drugs. Antihypertensive agents are used for…